ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition.

Lisa Hunihan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.